| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA632764 | P | Partition coefficient (logP) | 10 | small-molecule physicochemical format | Scientific Literature | |||
| 2. | ALA729098 | F | Number of animals protected or toxic compared to number tested in subcutaneous administration in mice; 1/1 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 3. | ALA729103 | F | Number of animals protected or toxic compared to number tested maximal electric shock (MES) method in Phase-I by intraperitoneal administration in mice; 3/3 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 4. | ALA728320 | F | Number of animals protected or toxic compared to number tested rotarod test in Phase-I by intraperitoneal administration in mice; 8/8 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA730614 | F | Anticonvulsant activity was measured as inhibition of convulsions by maximal electric shock (MES) method in Phase-I by intraperitoneal administration in mice | Mus musculus | 7 | organism-based format | Scientific Literature | ||
| 6. | ALA730615 | F | Anticonvulsant activity was measured as inhibition of convulsions by rotarod test in Phase-I by intraperitoneal administration in mice | Mus musculus | 7 | organism-based format | Scientific Literature | ||
| 7. | ALA730616 | F | Anticonvulsant activity was measured as inhibition of convulsions by subcutaneous administration in mice | Mus musculus | 7 | organism-based format | Scientific Literature | ||
| 8. | ALA736550 | F | Anticonvulsant activity was measured by maximal electric shock (MES) method in Phase -II by intraperitoneal administration in mice | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 9. | ALA736390 | F | Anticonvulsant activity of the compound, 0.5 hr after administration in maximal electroshock mice model | Mus musculus | 9 | organism-based format | Scientific Literature | ||
| 10. | ALA736391 | F | Anticonvulsant activity of the compound, 0.5 hr after administration of compound in mice subjected to subcutaneous metrazole challenge (85 mg/kg) | Mus musculus | 9 | organism-based format | Scientific Literature | ||
| 11. | ALA744595 | F | Anticonvulsant activity was measured by rotarod test in Phase -II by intraperitoneal administration in mice | Mus musculus | 6 | organism-based format | Scientific Literature | ||
| 12. | ALA745200 | A | Anticonvulsant activity of the compound,0.5 hr after administration in mice subjected to rotarod toxicity test | Mus musculus | 8 | organism-based format | Scientific Literature | ||
| 13. | ALA741941 | F | Time taken for measure Anticonvulsant activity in Phase -II by intraperitoneal administration in mice | Mus musculus | 6 | organism-based format | Scientific Literature | ||
| 14. | ALA804530 | B | Inhibition of binding to sodium channel of rat cerebral cortex | Rattus norvegicus | 11 | tissue-based format | Scientific Literature | ||
| 15. | ALA820383 | B | Displacement of [3H]BTX-B from rat cerebral cortex voltage-gated sodium channel, 0.25 hr after 160 uM | Rattus norvegicus | 1 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!